METOPIRONE Drug Patent Profile
✉ Email this page to a colleague
When do Metopirone patents expire, and what generic alternatives are available?
Metopirone is a drug marketed by Hra Pharma and is included in one NDA.
The generic ingredient in METOPIRONE is metyrapone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the metyrapone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOPIRONE?
- What are the global sales for METOPIRONE?
- What is Average Wholesale Price for METOPIRONE?
Summary for METOPIRONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 6 |
Patent Applications: | 1,460 |
Drug Prices: | Drug price information for METOPIRONE |
What excipients (inactive ingredients) are in METOPIRONE? | METOPIRONE excipients list |
DailyMed Link: | METOPIRONE at DailyMed |
Recent Clinical Trials for METOPIRONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rose Research Center, LLC | Phase 1/Phase 2 |
Foundation for a Smoke-Free World | Phase 1/Phase 2 |
Embera NeuroTherapeutics, Inc. | Phase 1/Phase 2 |
Pharmacology for METOPIRONE
Drug Class | Adrenal Steroid Synthesis Inhibitor |
Mechanism of Action | Adrenal Steroid Synthesis Inhibitors |
US Patents and Regulatory Information for METOPIRONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hra Pharma | METOPIRONE | metyrapone | CAPSULE;ORAL | 012911-002 | Aug 9, 1996 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hra Pharma | METOPIRONE | metyrapone | TABLET;ORAL | 012911-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |